longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CUE

CUE
----

LongbridgeAI

Cue Biopharma Chief Executive Officer Sold Shares Worth Over $1.6M

TradingView
Aug 15, 2026 at 12:50 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Cue Biopharma CEO Lin Shao-Lee sold shares worth $1.6 million in August 2026 to cover tax withholding obligations for restricted stock units. The transactions were non-discretionary, resulting in direct ownership of 705,995 shares.

Lin Shao-Lee, a Director and Chief Executive Officer, reported the sale of common stock in two transactions on August 12 and August 13, 2026. The sales were executed at weighted average prices of $26.99, $27.75, $27.19, $28.11 and $29.48 per share across the reported lots. The total sale amount reported was $1,606,562. Following the reported transactions, Lin Shao-Lee directly owned 705,995 shares of common stock. The filer states the sales were to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units and were not discretionary transactions.

Reporter NameLin Shao-Lee
RelationshipChief Executive Officer
TypeSell
Amount$1,606,562
SEC FilingForm 4
Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Login to unlock400characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Cue BioPharma

Cue BioPharma

CUE.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--